Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Oct 21, 2024

BUY
$80.59 - $92.61 $264,979 - $304,501
3,288 Added 37.46%
12,066 $1.03 Million
Q4 2023

Feb 07, 2024

BUY
$80.59 - $92.61 $972,398 - $1.12 Million
12,066 New
12,066 $1.03 Million
Q2 2023

Oct 21, 2024

BUY
$80.84 - $89.45 $450,925 - $498,952
5,578 Added 174.31%
8,778 $747,000
Q2 2023

Aug 07, 2023

BUY
$80.84 - $89.45 $450,925 - $498,952
5,578 Added 174.31%
8,778 $747,000
Q1 2023

Oct 21, 2024

BUY
$72.75 - $90.6 $232,800 - $289,920
3,200 New
3,200 $264,000
Q1 2023

May 03, 2023

BUY
$72.75 - $90.6 $232,800 - $289,920
3,200 New
3,200 $264,000
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $265,868 - $334,054
-2,395 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $212,556 - $287,280
2,395 New
2,395 $284,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.